L-carnitine improves the asthma control in children with moderate persistent asthma

A. S. Bediwy, M. Al-Biltagi, M. Isa, N. Helaly, D. D. El Lebedy (Tanta, Cairo, Egypt)

Source: Annual Congress 2013 –Asthma drugs: new findings
Session: Asthma drugs: new findings
Session type: Thematic Poster Session
Number: 4124
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. S. Bediwy, M. Al-Biltagi, M. Isa, N. Helaly, D. D. El Lebedy (Tanta, Cairo, Egypt). L-carnitine improves the asthma control in children with moderate persistent asthma. Eur Respir J 2013; 42: Suppl. 57, 4124

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013

The role of allergen immunotherpy in children with mild to moderate asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013


Safety of tiotropium in pre-school children with symptomatic persistent asthma
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Dysfunctional breathing in asthma is associated with poor asthma control after specialist management
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016

Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Prediction of asthma control and treatment changes in obstructive asthmatic children
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016


Long-term using of omalizumab in children with atopic severe persistent non-controlled asthma
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013

FeNO-guided management of asthma during pregnancy reduces respiratory symptoms and asthma diagnosis in childhood
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016

Patterns of nonadherence in children with severe asthma
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016


Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015

The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Magnesium deficiency correction for improvement of children bronchial asthma treatment results
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015


E-monitoring of asthma therapy to improve compliance in children (E-MATIC)
Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management
Year: 2015



FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016



Patients with asthma moderate and severe presents reduced moderate levels of physical activity, less aerobic conditioning and poorly control of the asthma
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015


Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Real life experience of omalizumab on selected children with severe allergic asthma
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016